91120-6

LOINC 2.82

Antithrombin in Platelet poor plasma by Chromo.no addition of heparin

AT III PPP Chromo.no added heparin

Definition

  • This term represents an antithrombin (AT) assay which, in contrast to typical AT assays, is performed in the ABSENCE of heparin. This assay is also known as "Progressive antithrombin assay." It is used to identify type IIb AT deficiency, which is caused by a mutation in the AT heparin binding site (HBS). In type IIb AT deficiency, AT activity is reduced in the presence of heparin but is normal in the absence of heparin.[PMID: 19141163] This term was created for, but is not limited in use to, the Biophen Antithrombin 5 assay's VARIANT Method, which is performed without heparin. In patients with type IIb AT deficiency, AT activity is expected to be normal in patients with an HBS mutation.

Component

  • Antithrombin

Specimen / system

  • PPP

Class

  • COAG

Property

  • RelCCnc

Scale

  • Qn

Method

  • Chromo.no addition of heparin

Related names

  • Anti thrombin; Antithrm; Antithrombin III; Antithrombn; Anti-Xa; AT; AT III; ATIII; Chromo.no added heparin; Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Hematology; Heme; Heparin cofactor I; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; RlCCnc; Thrombin inhibitor I

Index terms

  • Anti thrombin
  • Anti-Xa
  • Antithrm
  • Antithrombin III
  • Antithrombn
  • AT
  • AT III
  • ATIII
  • Chromo.no added heparin
  • Chromogenic assay
  • COAGULATION
  • ENZY
  • Enzymatic assay
  • Hematology
  • Heme
  • Heparin cofactor I
  • Plas
  • Platelet poor plasma
  • Point in time
  • QNT
  • Quan
  • Quant
  • Quantitative
  • Random
  • RlCCnc
  • Thrombin inhibitor I